For people who cannot undergo surgery, transcatheter mitral valve repair (TMVR) provides a newer, minimally invasive option for treating the most common form of mitral valve leakage.
We have several years of experience successfully implanting the MitraClip®, the first device approved by the Food and Drug Administration (FDA) for TMVR. If your heart’s mitral valve is allowing blood to leak backward, and you cannot undergo surgery, this procedure may correct the problem and improve your quality of life.
WHAT WE OFFER YOU FOR TMVR
- Minimally invasive option for those who cannot have open-heart surgery due to health reasons.
- Nationally recognized expertise, with an accomplished team of surgeons and interventional cardiologists who specialize in mitral valve repair.
- Leading-edge research program to expand and refine TMVR, including participation in the COAPT clinical trial using the MitraClip to treat the functional form of mitral regurgitation.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.